Department of Machine Learning, Moffitt Cancer Center, Tampa, Florida, USA.
Thayer School of Engineering, Dartmouth College, Hanover, New Hampshire, USA.
Med Phys. 2022 Jun;49(6):4109-4122. doi: 10.1002/mp.15662. Epub 2022 Apr 18.
FLASH radiotherapy (FLASH-RT) is an emerging ultra-high dose (>40 Gy/s) delivery that promises to improve the therapeutic potential by limiting toxicities compared to conventional RT while maintaining similar tumor eradication efficacy. Image guidance is an essential component of modern RT that should be harnessed to meet the special emerging needs of FLASH-RT and its associated high risks in planning and delivering of such ultra-high doses in short period of times. Hence, this contribution will elaborate on the imaging requirements and possible solutions in the entire chain of FLASH-RT treatment, from the planning, through the setup and delivery with online in vivo imaging and dosimetry, up to the assessment of biological mechanisms and treatment response. In patient setup and delivery, higher temporal sampling than in conventional RT should ensure that the short treatment is delivered precisely to the targeted region. Additionally, conventional imaging tools such as cone-beam computed tomography will continue to play an important role in improving patient setup prior to delivery, while techniques based on magnetic resonance imaging or positron emission tomography may be extremely valuable for either linear accelerator (Linac) or particle FLASH therapy, to monitor and track anatomical changes during delivery. In either planning or assessing outcomes, quantitative functional imaging could supplement conventional imaging for more accurate utilization of the biological window of the FLASH effect, selecting for or verifying things such as tissue oxygen and existing or transient hypoxia on the relevant timescales of FLASH-RT delivery. Perhaps most importantly at this time, these tools might help improve the understanding of the biological mechanisms of FLASH-RT response in tumor and normal tissues. The high dose deposition of FLASH provides an opportunity to utilize pulse-to-pulse imaging tools such as Cherenkov or radiation acoustic emission imaging. These could provide individual pulse mapping or assessing the 3D dose delivery superficially or at tissue depth, respectively. In summary, the most promising components of modern RT should be used for safer application of FLASH-RT, and new promising developments could be advanced to cope with its novel demands but also exploit new opportunities in connection with the unique nature of pulsed delivery at unprecedented dose rates, opening a new era of biological image guidance and ultrafast, pulse-based in vivo dosimetry.
FLASH 放疗(FLASH-RT)是一种新兴的超高剂量(>40 Gy/s)输送方式,有望通过限制毒性,与常规放疗相比提高治疗潜力,同时保持类似的肿瘤清除效果。图像引导是现代放疗的一个重要组成部分,应该利用它来满足 FLASH-RT 的特殊新兴需求及其在短时间内输送如此超高剂量的相关高风险。因此,本贡献将详细阐述 FLASH-RT 治疗整个链条中的成像要求和可能的解决方案,从规划到在线体内成像和剂量学的设置和输送,直到生物机制和治疗反应的评估。在患者设置和输送中,比常规 RT 更高的时间采样应确保短时间内精确输送到目标区域。此外,传统的成像工具,如锥形束计算机断层扫描(CBCT),将继续在治疗前改善患者设置中发挥重要作用,而基于磁共振成像(MRI)或正电子发射断层扫描(PET)的技术对于线性加速器(Linac)或粒子 FLASH 治疗可能具有极高的价值,以在输送过程中监测和跟踪解剖结构的变化。在规划或评估结果时,定量功能成像可以补充传统成像,更准确地利用 FLASH 效应的生物学窗口,选择或验证组织氧和相关时间尺度上的现有或瞬态缺氧等因素。也许此时最重要的是,这些工具可能有助于提高对肿瘤和正常组织中 FLASH-RT 反应的生物学机制的理解。FLASH 的高剂量沉积为利用脉冲到脉冲成像工具提供了机会,如切伦科夫或辐射声发射成像。这些可以分别提供单个脉冲映射或评估 3D 剂量输送的表面或组织深度。总之,现代 RT 中最有前途的组成部分应该用于更安全地应用 FLASH-RT,并且可以推进新的有前途的发展,以应对其新的需求,同时利用与前所未有的剂量率下脉冲输送的独特性质相关的新机会,开辟生物图像引导和超快、基于脉冲的体内剂量学的新时代。